Q BioMed Inc

Company Profile

q biomed inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. the company offers strontium chloride sr89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies; and metastron, a radiopharmaceutical drug for metastatic cancer bone pain therapy. it is also developing man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; qbm-001 for rare pediatric non-verbal autism spectrum disorder; and uttroside-b for liver cancer. q biomed inc. has a partnership with mannin research for the development of novel covid-19 therapeutics. the company was formerly known as ismo tech solutions, inc. and changed its name to q biomed inc. in july 2015. q biomed inc. was founded in 2013 and is based in new york, new york.